| Metric | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | — | $0.0B |
| Cost of Revenue | $0.1B | $0.1B | $0.1B | $0.1B | — | — |
| Gross Profit | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.6B | $0.7B | $0.8B | $0.5B | $-0.0B |
| Net Income | $0.5B | $0.3B | $0.4B | $0.4B | $0.4B | $-0.0B |
| EPS (Basic) | $7.26 | $1.72 | $1.07 | $0.88 | $2.59 | $0.31 |
| EPS (Diluted) | $7.22 | $1.70 | $1.07 | $0.87 | $2.57 | $0.31 |
| Metric | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|
| Total Assets | $12.6B | $9.7B | $9.6B | $10.3B | $9.6B | $1.7B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B |
| Total Liabilities | $9.6B | $7.1B | $7.1B | $7.9B | $7.4B | $0.0B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $3.1B | $2.6B | $2.5B | $2.2B | $2.1B | $1.7B |
| Metric | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $0.9B | $1.1B | — | — | — |
| Investing Cash Flow | $-3.2B | $-0.5B | $-0.0B | — | — | — |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $1.9B | $-0.5B | $-1.0B | — | — | — |